NFE2L2 and adenocarcinoma: Nrf2 and p62 are independent prognostic factors for non-small cell lung cancer (SCLC) in patients with adenocarcinoma, suggesting that molecular mechanisms in the evolution of cancer are different in adenocarcinoma- and squamous cell carcinoma [89].